Autologous Micrograft Technology and Finasteride for the Management of Androgenic Alopecia: A Systematic Review and Meta-Analysis of Efficacy and Safety

This systematic review and meta-analysis evaluated the effectiveness of Autologous Micrograft Technology (AMT) compared to finasteride in treating androgenetic alopecia (AGA). The findings suggest that AMT may be more effective, with a medium effect size (Hedges’s g = 0.634) in the percentage of patients benefiting from the treatment, compared to finasteride's small effect size (Hedges’s g = 0.201). While both treatments showed small effect sizes in improving hair count, AMT had a more significant overall impact. The study concludes that AMT is an effective method for promoting hair growth in AGA patients and is superior to finasteride.